Imagine a world where the agonizing wait for a life-saving kidney transplant could end for thousands—potentially through organs sourced from pigs. This isn't science fiction; it's the thrilling frontier of xenotransplantation, where animal organs might soon bridge the desperate gap in human donations. But here's where it gets controversial: Are we ready to cross species lines for medicine, or does this raise ethical red flags that could stall progress? Stick around as we dive into the groundbreaking developments of 2025 and explore why this could revolutionize kidney care—or spark intense debate.
Pioneering New Paths in Transplants: The Rise of Kidney Xenotransplants
Exciting breakthroughs in kidney xenotransplantation during 2025 have propelled pig-to-human kidney transplants toward becoming a practical medical option, especially as the shortage of donor organs continues to worsen.
In the US alone, over 100,000 individuals are currently on the waitlist for organ transplants. Among them, nearly 90,000 are urgently awaiting a kidney, and tragically, about 11 people pass away daily without ever getting the organ they so desperately need.¹ ²
The demand for kidneys vastly outpaces the available supply, creating a crisis that affects countless lives. Yet, a resurgence of enthusiasm and notable strides in cross-species organ transplants, termed xenotransplantation, hold promise to transform the landscape of kidney treatments entirely.
A Journey Through Time: The Evolution of Xenotransplant Research Leading to 2025
While the buzz around kidney xenotransplantation peaked in 2025, its roots go back over five decades. Research gained traction in the 1960s, with scientists testing nonhuman primates as kidney donors, though outcomes were disappointing. By the 1990s, pigs became the favored choice, thanks to their similar body structures, plentiful numbers, and the ability to modify their genes on a grand scale.³ ⁴
After years of dedicated study, 2021 marked a milestone with successful implants of altered pig kidneys into individuals who were brain-dead, conducted at the University of Alabama and NYU Langone Health.⁴
In an interview with HCPLive, Robert Montgomery, MD, PhD, who leads the Department of Surgery and directs the NYU Langone Transplant Institute, shared insights on this pivotal moment: “What truly opened doors was placing these organs into deceased patients, monitoring them for 1 to 2 months, and confirming no risky pathogens were being transferred. This built crucial confidence for future compassionate use cases in kidney xenotransplants.”
Building on that, 2024 saw Massachusetts General Hospital achieve a historic first by transplanting a genetically tweaked pig kidney into a living patient suffering from end-stage kidney disease (ESKD), although the kidney functioned for only two months before the recipient sadly succumbed.⁴
“Xenotransplantation stands out as the most exhilarating development in kidney transplants I've witnessed,” Pranav Garimella, the chief medical officer at the American Kidney Fund, remarked to HCPLive. “It's not a novel idea—it's been studied extensively—but now we're seeing genuine enhancements in patient results and longer-lasting pig kidneys.”
Key Milestones of 2025
The pace of innovation surged in early 2025, starting with Massachusetts General Hospital conducting its second successful transplant of a gene-edited pig kidney into a living patient in January. This was done via the FDA's Expanded Access Protocol (EAP), which grants access to experimental therapies for people with severe conditions lacking alternatives. The kidney featured 69 genetic modifications, supplied by eGenesis.⁵
The recipient, a 66-year-old man, had endured over two years of dialysis due to end-stage kidney disease (ESKD). Dialysis isn't just inconvenient; it imposes a heavy daily burden, and his rare O-group blood type further prolonged his wait for a human kidney.⁵
Shortly after, the FDA approved the inaugural clinical trials for xenokidneys, featuring United Therapeutics' investigational UKidney™ from a pig with 10 gene edits and eGenesis' version with 69 edits. These trials aim to support a Biologics License Application, beginning with 6 ESKD patients and potentially expanding to 50, focusing on those unsuitable for traditional human kidney transplants or facing slim chances of receiving a deceased donor organ within five years.⁶ ⁷
“I've dedicated decades to this field,” Richard Knight, MD, medical director of transplant diagnostics at Thermo Fisher Scientific, told HCPLive. “When I began as a young surgeon, xenotransplantation felt like a distant lab fantasy with impossible hurdles. Many talented researchers abandoned it, but the leaps this year have been astounding.”
Approaching a Viable Medical Breakthrough?
Experts agree that while progress is remarkable, xenotransplantation isn't yet suitable for everyday clinical use. Montgomery highlights that initial pig kidney transplants have surprisingly functioned well right from the start, avoiding the rapid rejection issues that derailed primate experiments.
However, challenges persist in immunology, particularly the risk of transmitting animal-borne infections to people. There's also a pressing need for immunosuppressive drugs that fend off organ rejection without leaving patients vulnerable to infections.⁴
“The barriers for xenografts are massive, yet they've overcome huge ground,” Knight added in his HCPLive discussion. “A secondary worry is the potential spread of pig viruses to humans, but this can be managed by selective breeding and reducing viral activity.”
Montgomery cautioned, “Admittedly, this is intricate technology. No emerging treatment starts perfected; the genetic tweaks and anti-rejection drugs will improve over time.”
Beyond safety, the durability of these organs is still unproven. Human kidneys from living donors typically endure 15 to 20 years, while those from deceased donors last 8 to 12 years. Pig kidney data so far shows functionality for just a few months.⁸
For that reason, Garimella views xenotransplantation mainly as a temporary solution leading to a human kidney transplant: “It's unclear if these pig kidneys will match the longevity of human ones, lasting 5, 10, 15, or 20 years.”
Both he and Montgomery liken it to the role of left ventricular assist devices (LVADs) in heart transplants, suggesting pig kidneys might serve as either a bridge to a full transplant or, in some scenarios, a long-term option.
Moral, Regulatory, and Logistical Dilemmas
If xenotransplantation becomes a standard fix for the organ shortage, Garimella emphasizes tackling moral, regulatory, and practical obstacles for widespread adoption.
Knight raises questions about scalability, noting the necessity for hundreds or thousands of such procedures annually, plus affordability.
“We can invent brilliant medical solutions,” he said, “but if they're prohibitively costly, they won't succeed. I'm eager to learn if this can be scaled economically.”
Future Prospects
The achievements of 2025 signal a fresh chapter, not the conclusion, and optimism abounds that xenotransplantation could provide hope for patients with limited alternatives.
“Besides living and deceased donor options, xenotransplantation is the next frontier,” Knight noted. “Clinicians are thrilled by the possibility of offering transplants to those who otherwise have none.”
And this is the part most people miss: What if pig kidneys become not just a stopgap but a permanent fix, blurring the lines between human and animal biology? Could this lead to a future where we routinely mix species for health, or does it open Pandora's box on animal rights and human dignity? Do you think the benefits outweigh the ethical concerns, or should we prioritize boosting human donations instead? Sound off in the comments—do you agree, disagree, or have a counterpoint? Your thoughts could fuel the conversation!
References
Health Resources & Services Administration. Organ Donation Statistics. May 2025. Accessed December 11, 2025. https://www.organdonor.gov/learn/organ-donation-statistics
UNOS. 90,000 people are waiting for a kidney. Here's one way to get them a kidney faster. January 27, 2025. Accessed December 11, 2025. https://unos.org/news/90000-people-are-waiting-for-a-kidney-heres-one-way-to-get-them-a-kidney-faster/
Cooper DKC, Ekser B, Tector AJ. A brief history of clinical xenotransplantation. Int J Surg. 2015;23(Pt B):205-210. doi:10.1016/j.ijsu.2015.06.060
National Kidney Foundation. Breaking Ground in Transplantation: A New Era with Xenotransplantation. May 31, 2024. Accessed December 11, 2025. https://www.kidney.org/news-stories/breaking-ground-transplantation-new-era-xenotransplantation
Brooks A. Second Xenotransplant with Gene-Edited Pig Kidney Performed at Mass General. HCPLive. February 7, 2025. Accessed December 11, 2025. https://www.hcplive.com/view/mass-general-performs-second-xenotransplant-gene-edited-pig-kidney
Brooks A. FDA Clears First Xenotransplant Trial for Gene-Edited Kidneys. HCPLive. February 3, 2025. Accessed December 11, 2025. https://www.hcplive.com/view/fda-clears-first-xenotransplant-trial-gene-edited-kidneys
Deeley M. FDA greenlights first clinical trials for genetically modified pig kidney transplants in humans. American Kidney Fund. February 6, 2025. Accessed December 11, 2025. https://www.kidneyfund.org/article/fda-greenlights-first-clinical-trials-genetically-modified-pig-kidney-transplants-humans
National Kidney Fund. Kidney Transplant. March 15, 2024. Accessed December 11, 2025. https://www.kidney.org/kidney-topics/kidney-transplant
Newsletter
Join thousands of healthcare professionals keeping up with cutting-edge treatments, study findings, and expert perspectives—sign up for HCPLive now!**
